Amid Chinese Pressure Biden To Boost US Biomanufacturing

President Biden wants to increase federal expenditure on biotech to optimise its potential since China, in particular, is actively engaging in this industry.

Despite Rising Illness, Cambodian Pharma Sees Less Potential

The quality of medical treatment that is available in publicly funded hospitals has suffered as a direct result of an inadequate support from the government.

EU Officials Make New Work Plan To Speed-Up Clinical Study

The objective is to boost the reputation of EU as a centre for clinical research as well as promote the development of efficacious, high-quality medicines.

FDA And NIH Working Together To Discover More About ALS

The pharmaceutical sector lays a significant focus on finding a remedy as soon as possible due to the progressive nature of the diseases, which can be fatal.

Discoveries About Lumakra Lung Cancer Bolster The KRAS Fight

Lumakras significantly slowed down the progression of disease in patients with KRAS G12C-mutated non-small cell lung cancer by 34% when compared to docetaxel.

Australia Permits New Treatment For Rare Bile Duct Cancer

Cholangiocarcinoma is rare kind of cancer that affects bile ducts and government of Australia has given go-ahead for new targeted medicine to treat the disease.

COVID Increases Long-Term Brain Injury Concern- US Study

One-year study, published in Nature Medicine, used anonymous health records from millions of US vets to assess cognitive abilities in 44 different conditions.

WHO Demands More Study On People Living With Long COVID

The WHO has requested expanded investigation on COVID because it is becoming increasingly common and more studies are needed to understand and manage it better.